UTMD
Price
$70.52
Change
+$0.95 (+1.37%)
Updated
Jul 31 closing price
Capitalization
224.54M
Intraday BUY SELL Signals
VMD
Price
$11.67
Change
-$0.09 (-0.77%)
Updated
Jul 31 closing price
Capitalization
447.39M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

UTMD vs VMD

UTMD vs VMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
UTMD vs. VMD commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UTMD is a Buy and VMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (UTMD: $70.52 vs. VMD: $11.67)
Brand notoriety: UTMD and VMD are both not notable
UTMD represents the Pharmaceuticals: Other, while VMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: UTMD: 79% vs. VMD: 120%
Market capitalization -- UTMD: $224.54M vs. VMD: $447.39M
UTMD [@Pharmaceuticals: Other] is valued at $224.54M. VMD’s [@Medical/Nursing Services] market capitalization is $447.39M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $124.82B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $182.9B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.1B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

UTMD’s FA Score shows that 2 FA rating(s) are green whileVMD’s FA Score has 1 green FA rating(s).

  • UTMD’s FA Score: 2 green, 3 red.
  • VMD’s FA Score: 1 green, 4 red.
According to our system of comparison, UTMD is a better buy in the long-term than VMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UTMD’s TA Score shows that 6 TA indicator(s) are bullish while VMD’s TA Score has 4 bullish TA indicator(s).

  • UTMD’s TA Score: 6 bullish, 3 bearish.
  • VMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, UTMD is a better buy in the short-term than VMD.

Price Growth

UTMD (@Pharmaceuticals: Other) experienced а +5.03% price change this week, while VMD (@Medical/Nursing Services) price change was -0.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.03%. For the same industry, the average monthly price growth was +0.09%, and the average quarterly price growth was -1.71%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.50%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -17.67%.

Reported Earning Dates

VMD is expected to report earnings on Aug 03, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+5.03% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VMD($447M) has a higher market cap than UTMD($225M). VMD has higher P/E ratio than UTMD: VMD (31.54) vs UTMD (21.49). VMD YTD gains are higher at: 57.066 vs. UTMD (27.217). VMD has higher annual earnings (EBITDA): 53M vs. UTMD (13.9M). UTMD has more cash in the bank: 87.4M vs. VMD (9.76M). UTMD has less debt than VMD: UTMD (210K) vs VMD (12.4M). VMD has higher revenues than UTMD: VMD (287M) vs UTMD (37.5M).
UTMDVMDUTMD / VMD
Capitalization225M447M50%
EBITDA13.9M53M26%
Gain YTD27.21757.06648%
P/E Ratio21.4931.5468%
Revenue37.5M287M13%
Total Cash87.4M9.76M895%
Total Debt210K12.4M2%
FUNDAMENTALS RATINGS
UTMD vs VMD: Fundamental Ratings
UTMD
VMD
OUTLOOK RATING
1..100
8550
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
7670
PRICE GROWTH RATING
1..100
4538
P/E GROWTH RATING
1..100
1916
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTMD's Valuation (15) in the Medical Specialties industry is somewhat better than the same rating for VMD (69) in the null industry. This means that UTMD’s stock grew somewhat faster than VMD’s over the last 12 months.

VMD's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for UTMD (100) in the Medical Specialties industry. This means that VMD’s stock grew somewhat faster than UTMD’s over the last 12 months.

VMD's SMR Rating (70) in the null industry is in the same range as UTMD (76) in the Medical Specialties industry. This means that VMD’s stock grew similarly to UTMD’s over the last 12 months.

VMD's Price Growth Rating (38) in the null industry is in the same range as UTMD (45) in the Medical Specialties industry. This means that VMD’s stock grew similarly to UTMD’s over the last 12 months.

VMD's P/E Growth Rating (16) in the null industry is in the same range as UTMD (19) in the Medical Specialties industry. This means that VMD’s stock grew similarly to UTMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
UTMDVMD
RSI
ODDS (%)
Bearish Trend 5 days ago
50%
Bearish Trend 4 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 4 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
60%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
50%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
72%
Aroon
ODDS (%)
Bearish Trend 4 days ago
49%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
UTMD
Daily Signal:
Gain/Loss:
VMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGSX31.780.24
+0.76%
Fidelity Series Growth Company
SMDRX22.360.15
+0.68%
Hartford Schroders US MidCap Opps SDR
ETGLX61.100.15
+0.25%
Eventide Gilead N
JMNSX15.270.02
+0.13%
JPMorgan Research Market Neutral I
MADRX27.040.02
+0.07%
Madison Dividend Income R6

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
+1.37%
CERS - UTMD
50%
Loosely correlated
-25.61%
TMCI - UTMD
47%
Loosely correlated
-1.60%
INMD - UTMD
47%
Loosely correlated
+0.30%
ITGR - UTMD
44%
Loosely correlated
+20.18%
IART - UTMD
43%
Loosely correlated
-2.75%
More

VMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, VMD has been loosely correlated with UTMD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VMD jumps, then UTMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VMD
1D Price
Change %
VMD100%
-0.77%
UTMD - VMD
35%
Loosely correlated
+1.37%
INMD - VMD
35%
Loosely correlated
+0.30%
MXCT - VMD
34%
Loosely correlated
N/A
KIDS - VMD
32%
Poorly correlated
+0.40%
ATEC - VMD
32%
Poorly correlated
-1.45%
More